Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female patients ≥18 years old~* Patients who have (or will have) an arterial line, which was (will be) inserted for clinical - need, will be considered for inclusion in this study~* Patients who give informed consent (or their personal/nominated consultee) to participate in the study~* Patients who are likely to have an arterial line for at least 6 hours.~Exclusion Criteria:~* Patients contraindicated for an arterial line~* Refusal of consent by a patient~* Not for use with patients with uncorrected hyperphosphataemia, hypocalcaemia or hypercalcaemia.~* The patient is considered to be unsuitable for the study by the investigator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Conventional ABG analyser (Type: ACTIVE_COMPARATOR): None
- Proxima 3® arterial blood gas (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).